REPORT ID 3341

United States Platelet Rich Plasma Market Report 2017

Publish Date
13-Dec-17
Pages
95
Format
Electronic (PDF)

In this report, the United States Platelet Rich Plasma market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Platelet Rich Plasma in these regions, from 2012 to 2022 (forecast).

United States Platelet Rich Plasma market competition by top manufacturers/players, with Platelet Rich Plasma sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Harvest Technologies
    DePuy Synthes
    Stryker
    Zimmer Biomet
    Arthrex
    Exactech
    Emcyte Corporation
    Arteriocyte
    Adilyfe

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    P-PRP
    L-PRP
    L-PRF
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Orthopedic Surgery
    Cosmetic Surgery
    General Surgery
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Platelet Rich Plasma Market Report 2017
1 Platelet Rich Plasma Overview
    1.1 Product Overview and Scope of Platelet Rich Plasma
    1.2 Classification of Platelet Rich Plasma by Product Category
        1.2.1 United States Platelet Rich Plasma Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Platelet Rich Plasma Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 P-PRP
        1.2.4 L-PRP
        1.2.5 L-PRF
    1.3 United States Platelet Rich Plasma Market by Application/End Users
        1.3.1 United States Platelet Rich Plasma Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Orthopedic Surgery
        1.3.3 Cosmetic Surgery
        1.3.4 General Surgery
        1.3.5 Other
    1.4 United States Platelet Rich Plasma Market by Region
        1.4.1 United States Platelet Rich Plasma Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Platelet Rich Plasma Status and Prospect (2012-2022)
        1.4.3 Southwest Platelet Rich Plasma Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Platelet Rich Plasma Status and Prospect (2012-2022)
        1.4.5 New England Platelet Rich Plasma Status and Prospect (2012-2022)
        1.4.6 The South Platelet Rich Plasma Status and Prospect (2012-2022)
        1.4.7 The Midwest Platelet Rich Plasma Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Platelet Rich Plasma (2012-2022)
        1.5.1 United States Platelet Rich Plasma Sales and Growth Rate (2012-2022)
        1.5.2 United States Platelet Rich Plasma Revenue and Growth Rate (2012-2022)

2 United States Platelet Rich Plasma Market Competition by Players/Suppliers
    2.1 United States Platelet Rich Plasma Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Platelet Rich Plasma Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Platelet Rich Plasma Average Price by Players/Suppliers (2012-2017)
    2.4 United States Platelet Rich Plasma Market Competitive Situation and Trends
        2.4.1 United States Platelet Rich Plasma Market Concentration Rate
        2.4.2 United States Platelet Rich Plasma Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Platelet Rich Plasma Manufacturing Base Distribution, Sales Area, Product Type

3 United States Platelet Rich Plasma Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Platelet Rich Plasma Sales and Market Share by Region (2012-2017)
    3.2 United States Platelet Rich Plasma Revenue and Market Share by Region (2012-2017)
    3.3 United States Platelet Rich Plasma Price by Region (2012-2017)

4 United States Platelet Rich Plasma Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Platelet Rich Plasma Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Platelet Rich Plasma Revenue and Market Share by Type (2012-2017)
    4.3 United States Platelet Rich Plasma Price by Type (2012-2017)
    4.4 United States Platelet Rich Plasma Sales Growth Rate by Type (2012-2017)

5 United States Platelet Rich Plasma Sales (Volume) by Application (2012-2017)
    5.1 United States Platelet Rich Plasma Sales and Market Share by Application (2012-2017)
    5.2 United States Platelet Rich Plasma Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Platelet Rich Plasma Players/Suppliers Profiles and Sales Data
    6.1 Harvest Technologies
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Platelet Rich Plasma Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Harvest Technologies Platelet Rich Plasma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 DePuy Synthes
        6.2.2 Platelet Rich Plasma Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 DePuy Synthes Platelet Rich Plasma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Stryker
        6.3.2 Platelet Rich Plasma Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Stryker Platelet Rich Plasma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Zimmer Biomet
        6.4.2 Platelet Rich Plasma Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Zimmer Biomet Platelet Rich Plasma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Arthrex
        6.5.2 Platelet Rich Plasma Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Arthrex Platelet Rich Plasma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Exactech
        6.6.2 Platelet Rich Plasma Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Exactech Platelet Rich Plasma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Emcyte Corporation
        6.7.2 Platelet Rich Plasma Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Emcyte Corporation Platelet Rich Plasma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Arteriocyte
        6.8.2 Platelet Rich Plasma Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Arteriocyte Platelet Rich Plasma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Adilyfe
        6.9.2 Platelet Rich Plasma Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Adilyfe Platelet Rich Plasma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Platelet Rich Plasma Manufacturing Cost Analysis
    7.1 Platelet Rich Plasma Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Platelet Rich Plasma

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Platelet Rich Plasma Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Platelet Rich Plasma Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Platelet Rich Plasma Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Platelet Rich Plasma Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Platelet Rich Plasma Sales Volume Forecast by Type (2017-2022)
    11.3 United States Platelet Rich Plasma Sales Volume Forecast by Application (2017-2022)
    11.4 United States Platelet Rich Plasma Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer